Results 21 to 30 of about 529,428 (208)

Malignant hyperthermia: patient undergoing limb debridement surgery—a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Malignant hyperthermia is a rare but potentially fatal clinical emergency, primarily triggered by inhaled volatile anesthetics. It is associated with inherited autosomal-dominant skeletal muscle disorders and typically caused by mutations in ...
Zhixiang Geng   +6 more
doaj   +2 more sources

Humidity impacts volatile anesthetic and heat responses of malignant hyperthermia susceptible mice [PDF]

open access: yesSkeletal Muscle
Background Malignant Hyperthermia (MH) is characterized by life-threatening whole-body hyperthermic reactions triggered by volatile anesthetics in susceptible individuals.
Miao He   +9 more
doaj   +2 more sources

Successful management of malignant hyperthermia without dantrolene: A case report [PDF]

open access: yesJournal of International Medical Research
Malignant hyperthermia during surgery represents a significant challenge for anesthesiologists due to its high mortality rate and the risk of long-term physiological damage.
Cailing Zhang   +3 more
doaj   +2 more sources

Acute postoperative sepsis mimicking symptomology suspicious for malignant hyperthermia: case report [PDF]

open access: yesRevista Brasileira de Anestesiologia, 2020
Background: Sepsis is a life-threatening organ dysfunction with non-specific clinical features that can mimic other clinical conditions with hyper metabolic state such as malignant hyperthermia.
Vendhan Ramanujam   +3 more
doaj   +5 more sources

Malignant Hyperthermia in PICU—From Diagnosis to Treatment in the Light of Up-to-Date Knowledge

open access: yesChildren, 2022
Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile anesthetics and succinylcholine. Rarely, MH can occur after non-pharmacological triggers too. MH was detected more often in children and young adults, which
Martina Klincová   +4 more
doaj   +1 more source

Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil [PDF]

open access: yesRevista Brasileira de Anestesiologia, 2019
Background and objectives: Malignant hyperthermia is an autosomal dominant hypermetabolic pharmacogenetic syndrome, with a mortality rate of 10%–20%, which is triggered by the use of halogenated inhaled anesthetics or muscle relaxant succinylcholine. The
Helga Cristina Almeida da Silva   +7 more
doaj   +5 more sources

Malignant hyperthermia [PDF]

open access: yesPostgraduate Medical Journal, 1998
SummaryMalignant hyperthermia is a rare autosomal dominant trait that predisposes affected individuals to great danger when exposed to certain anaesthetic triggering agents (such as potent volatile anaesthetics and succinylcholine). A sudden hypermetabolic reaction in skeletal muscle leading to hyperthermia and massive rhabdomyolysis can occur.
R, Ben Abraham   +3 more
openaire   +4 more sources

Impact of a digital manual for guidance on malignant hyperthermia: patient education

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Malignant hyperthermia (MH) is a rare, hereditary disease with a hypermetabolic response to volatile anesthetics/succinylcholine. Susceptible patients face difficulties due to a lack of knowledge about MH.
Gislene Rodrigues   +4 more
doaj   +1 more source

Malignant hyperthermia: a case report with a literature review [PDF]

open access: yesArchives of Aesthetic Plastic Surgery, 2022
Malignant hyperthermia is an extremely rare, potentially lethal disorder that occurs in susceptible patients who are exposed to triggering agents such as volatile anesthetic gases or depolarizing muscle relaxants. The clinical manifestations of malignant
Ji Hoon Kim   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy